Skip to main content
Top
Published in: Supportive Care in Cancer 7/2011

01-07-2011 | Letter to the Editor

Vitamin D depletion: of clinical significance in advanced cancer?

Authors: Carol A. Stone, Rose Anne Kenny, Martin Healy, J. Bernard Walsh, Peter G. Lawlor

Published in: Supportive Care in Cancer | Issue 7/2011

Login to get access

Excerpt

Evidence has been emerging from laboratory-based and epidemiological studies, over the past two decades, to suggest that that vitamin D has a much bigger role than previously thought; most tissues and cells in the body have vitamin D receptors and many others, in addition to the kidneys, have the capacity to hydroxylate 25-hydroxyvitamin D to the active 1,25-hydroxyvitamin D (1,25-(OH)2D). Data from observational population-based and preclinical studies implicate vitamin D deficiency in the pathogenesis of cancers, autoimmune and other common diseases [13]. …
Literature
2.
go back to reference Ma Y, Trump D, Johnson C (2010) Vitamin D in combination cancer treatment. J Cancer 1:101–107PubMed Ma Y, Trump D, Johnson C (2010) Vitamin D in combination cancer treatment. J Cancer 1:101–107PubMed
3.
go back to reference Trump DL, Deeb KK, Johnson CS (2010) Vitamin D: considerations in the continued development as an agent for cancer prevention and therapy. Cancer J 16(1):1–9PubMedCrossRef Trump DL, Deeb KK, Johnson CS (2010) Vitamin D: considerations in the continued development as an agent for cancer prevention and therapy. Cancer J 16(1):1–9PubMedCrossRef
4.
go back to reference Macdonald H, Mavroeidi A, Reid D, Fraser W (2010) Sunlight or diet: what is the answer for providing sufficient vitamin D in the UK? Br J Dermatol 163(2):434–435PubMedCrossRef Macdonald H, Mavroeidi A, Reid D, Fraser W (2010) Sunlight or diet: what is the answer for providing sufficient vitamin D in the UK? Br J Dermatol 163(2):434–435PubMedCrossRef
5.
go back to reference Wang T, Zhang F, Richards J, Kestenbaum B, van Meurs J, Berry D, Kiel DP (2010) Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet 376:180–188PubMedCrossRef Wang T, Zhang F, Richards J, Kestenbaum B, van Meurs J, Berry D, Kiel DP (2010) Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet 376:180–188PubMedCrossRef
6.
go back to reference Hagenau T, Vest R, Gissel TN, Poulsen CS, Erlandsen M, Mosekilde L, Vestergaard P (2009) Global vitamin D levels in relation to age, gender, skin pigmentation and latitude: an ecologic meta-regression analysis. Osteoporos Int 20(1):133–140PubMedCrossRef Hagenau T, Vest R, Gissel TN, Poulsen CS, Erlandsen M, Mosekilde L, Vestergaard P (2009) Global vitamin D levels in relation to age, gender, skin pigmentation and latitude: an ecologic meta-regression analysis. Osteoporos Int 20(1):133–140PubMedCrossRef
7.
go back to reference Ross AC, Taylor CL, Yaktine AL, Del Vallo HB (2010) Dietary reference intakes for calcium and vitamin D. The Institute of Medicine of the National Academy Washington DC Ross AC, Taylor CL, Yaktine AL, Del Vallo HB (2010) Dietary reference intakes for calcium and vitamin D. The Institute of Medicine of the National Academy Washington DC
8.
go back to reference Vieth R, Bischoff-Ferrari H, Boucher BJ, Dawson-Hughes B, Garland CF, Heaney RP, Holick MF, Hollis BW, Lamberg-Allardt C, McGrath JJ, Norman AW, Scragg R, Whiting SJ, Willett WC, Zittermann A (2007) The urgent need to recommend an intake of vitamin D that is effective. Am J Clin Nutr 85(3):649–650PubMed Vieth R, Bischoff-Ferrari H, Boucher BJ, Dawson-Hughes B, Garland CF, Heaney RP, Holick MF, Hollis BW, Lamberg-Allardt C, McGrath JJ, Norman AW, Scragg R, Whiting SJ, Willett WC, Zittermann A (2007) The urgent need to recommend an intake of vitamin D that is effective. Am J Clin Nutr 85(3):649–650PubMed
10.
go back to reference Crew K, Shane E, Cremers S, McMahon D, Irani D, Hershman D (2009) High prevalence of vitamin D deficiency despite supplementation in premenopausal women with breast cancer undergoing adjuvant chemotherapy. J Clin Oncol 13:2151–2156CrossRef Crew K, Shane E, Cremers S, McMahon D, Irani D, Hershman D (2009) High prevalence of vitamin D deficiency despite supplementation in premenopausal women with breast cancer undergoing adjuvant chemotherapy. J Clin Oncol 13:2151–2156CrossRef
11.
go back to reference Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, Orav JE, Stuck AE, Theiler R, Wong JB, Egli A, Kiel DP, Henschkowski J (2009) Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ 339:b3692. doi:10.1136/bmj.b3692 PubMedCrossRef Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, Orav JE, Stuck AE, Theiler R, Wong JB, Egli A, Kiel DP, Henschkowski J (2009) Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ 339:b3692. doi:10.​1136/​bmj.​b3692 PubMedCrossRef
12.
go back to reference Bischoff-Ferrari H, Giovannucci E, Willett W, Dietrich T, Dawson-Hughes B (2006) Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple outcomes. Am J Clin Nutr 84:18–28PubMed Bischoff-Ferrari H, Giovannucci E, Willett W, Dietrich T, Dawson-Hughes B (2006) Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple outcomes. Am J Clin Nutr 84:18–28PubMed
13.
go back to reference Ceglia L (2009) Vitamin D and its role in skeletal muscle. Curr Opin Clin Nutr Metab Care 12(6):628–633PubMedCrossRef Ceglia L (2009) Vitamin D and its role in skeletal muscle. Curr Opin Clin Nutr Metab Care 12(6):628–633PubMedCrossRef
14.
go back to reference Tagliafico AS, Ameri P, Bovio M, Puntoni M, Capaccio E, Murialdo G, Martinoli C (2010) Relationship between fatty degeneration of thigh muscles and vitamin D status in the elderly: a preliminary MRI study. Am J Roentgenol 194(3):728–734CrossRef Tagliafico AS, Ameri P, Bovio M, Puntoni M, Capaccio E, Murialdo G, Martinoli C (2010) Relationship between fatty degeneration of thigh muscles and vitamin D status in the elderly: a preliminary MRI study. Am J Roentgenol 194(3):728–734CrossRef
15.
go back to reference Bischoff-Ferrari HA, Dietrich T, Orav JE, Hu FB, Zhang Y, Karlson E, Dawson-Hughes B (2004) Higher 25-hydroxyvitamin D concentrations are associated with better lower extremity function in both active and inactive persons aged >60 y. Am J Clin Nutr 80:752–758PubMed Bischoff-Ferrari HA, Dietrich T, Orav JE, Hu FB, Zhang Y, Karlson E, Dawson-Hughes B (2004) Higher 25-hydroxyvitamin D concentrations are associated with better lower extremity function in both active and inactive persons aged >60 y. Am J Clin Nutr 80:752–758PubMed
16.
go back to reference Brown D, Milroy R, Preston T (2006) The relationship between an inflammation-based prognostic score (Glasgow Prognostic Score) and serum biochemical variables in patients with advanced lung and gastrointestinal cancers. J Clin Pathol 60:705–708PubMedCrossRef Brown D, Milroy R, Preston T (2006) The relationship between an inflammation-based prognostic score (Glasgow Prognostic Score) and serum biochemical variables in patients with advanced lung and gastrointestinal cancers. J Clin Pathol 60:705–708PubMedCrossRef
17.
go back to reference Stechschulte S, Kirsner R, Federman D (2009) Vitamin D: bone and beyond, rationale and recommendations for supplementation. Am J Med 122:793–802PubMedCrossRef Stechschulte S, Kirsner R, Federman D (2009) Vitamin D: bone and beyond, rationale and recommendations for supplementation. Am J Med 122:793–802PubMedCrossRef
Metadata
Title
Vitamin D depletion: of clinical significance in advanced cancer?
Authors
Carol A. Stone
Rose Anne Kenny
Martin Healy
J. Bernard Walsh
Peter G. Lawlor
Publication date
01-07-2011
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 7/2011
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-011-1117-9

Other articles of this Issue 7/2011

Supportive Care in Cancer 7/2011 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine